Want to join the conversation?
$REGN and $SNY said SARIL-RA-MONARCH Phase 3 monotherapy study met its primary endpoint, showing that sarilumab was superior to adalimumab in improving symptoms in patients with active rheumatoid arthritis at week 24. Study also met secondary endpoints like other measures gauging improvements in signs and symptoms of RA and physical function.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!